Article: Accelerate Brain Cancer Cure Commends the Selection of Brain Cancer for Inclusion in The Cancer Genome Atlas Pilot Project

WASHINGTON, Sept. 13 /U.S. Newswire/ -- Accelerate Brain Cancer Cure today commended the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) for their announced selection of brain cancer, or glioblastoma (GBM), as one of three cancers being included in their first-ever pilot project for The Cancer Genome Atlas (TCGA).

The goal of TGCA is to map genetic changes associated with all types of cancer in the human genetic blueprint. The cancers that will be studied in the TCGA Pilot Project are GBM, lung and ovarian. These cancers were selected because of the availability of biospecimen collections that met TCGA's rigorous scientific, technical and ethical ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!